ArticleFrontiers in cellular and infection microbiology2025
Isolation and characterization of an enterovirus G strain causing diarrhea and gut microbiota dysbiosis in piglets.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Enterovirus G (EV-G) is a significant causative agent of diarrhea in piglets, complicating differential diagnosis and impeding effective control of porcine diarrheal diseases. Enhanced clinical surveillance and pathogenicity assessment of EVG are essential to inform disease prevention strategies. Methods: The EV-G strain was isolated and identified in MA-104 cells using plaque assay, immunofluorescence staining, viral replication kinetics analysis, and transmission electron microscopy. The complete genomic sequence was obtained for phylogenetic and recombination analysis. Five-day-old piglets were orally challenged with the prevalent EV-G strain, and pathogenicity was assessed based on diarrhea scoring, viral load quantification in feces and tissues, and histopathological examination. Gut microbiota dynamics were profiled via high-throughput 16S rRNA sequencing pre- and post-infection. Results: A recombinant G1 genotype EV-G strain, designated EVG-SH-2024, was successfully isolated. Phylogenetic analysis indicated its closest amino acid identity (94.7%) with KF985175, while recombination analysis suggested origin from genetic exchange between KF985175 and MN734577. Inoculation with EVG-SH-2024 induced mild diarrhea and persistent viral shedding in piglets, accompanied by significant tissue damage including neuronal vacuolation in the brain, pulmonary consolidation, and intestinal inflammatory infiltration. 16S rRNA sequencing revealed substantial gut microbiota dysbiosis post-infection, marked by an increase in pathogenic bacteria and a decline in beneficial microbes. Notably, the top ten differentially abundant species were predominantly short-chain fatty acid (SCFA)-producing bacteria, whose abundance showed a significant Spearman's rank correlation with pathogenicity indicators. Conclusion: This study reports the first isolation and characterization of a G1 subtype EV-G strain in Shanghai, China. Integrated pathogenicity and microbiota analyses demonstrated that EV-G infection reduces the abundance of SCFA-producing bacteria, with this reduction significantly correlated with disease severity. These findings suggest a potential role of SCFAs in EV-G pathogenesis and provide a basis for developing microbiota-targeted interventions against EV-G infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.